These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 8262952

  • 21. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [Abstract] [Full Text] [Related]

  • 22. Fibronectin-binding properties of the purified platelet glycoprotein IIb-IIIa complex.
    Parise LV, Phillips DR.
    J Biol Chem; 1986 Oct 25; 261(30):14011-7. PubMed ID: 3771519
    [Abstract] [Full Text] [Related]

  • 23. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
    Calvete JJ, Schäfer W, Mann K, Henschen A, González-Rodríguez J.
    Eur J Biochem; 1992 Jun 15; 206(3):759-65. PubMed ID: 1376688
    [Abstract] [Full Text] [Related]

  • 24. Binding site in human plasma fibronectin to HL-60 cells localizes in the C-terminal heparin-binding region independently of RGD and CS1.
    Fujita H, Mohri H, Kanamori H, Iwamatsu A, Okubo T.
    Exp Cell Res; 1995 Apr 15; 217(2):484-9. PubMed ID: 7698249
    [Abstract] [Full Text] [Related]

  • 25. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK, Bennett JS.
    J Biol Chem; 1985 Oct 05; 260(22):11891-4. PubMed ID: 2995350
    [Abstract] [Full Text] [Related]

  • 26. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
    Parise LV, Helgerson SL, Steiner B, Nannizzi L, Phillips DR.
    J Biol Chem; 1987 Sep 15; 262(26):12597-602. PubMed ID: 2957377
    [Abstract] [Full Text] [Related]

  • 27. The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin.
    Gartner TK, Taylor DB.
    Proc Soc Exp Biol Med; 1991 Oct 15; 198(1):649-55. PubMed ID: 1716370
    [Abstract] [Full Text] [Related]

  • 28. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.
    Deckmyn H, Stanssens P, Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I, Vermylen J.
    Br J Haematol; 1994 Jul 15; 87(3):562-71. PubMed ID: 7993797
    [Abstract] [Full Text] [Related]

  • 29. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE.
    Thromb Res; 2007 Jul 15; 119(5):601-7. PubMed ID: 16860375
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM, Houghten RA, Russell SR, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5708-12. PubMed ID: 3016716
    [Abstract] [Full Text] [Related]

  • 31. Identification of two distinct regions within the binding sites for fibrinogen and fibronectin on the IIb-IIIa human platelet membrane glycoprotein complex by monoclonal antibodies P2 and P4.
    McGregor JL, McGregor L, Bauer AS, Catimel B, Brochier J, Dechavanne M, Clemetson KJ.
    Eur J Biochem; 1986 Sep 15; 159(3):443-9. PubMed ID: 2944746
    [Abstract] [Full Text] [Related]

  • 32. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E, Lévy-Toledano S, Rendu F, Hermant L, Lu H, Fiat AM, Jollès P, Caen J.
    Eur J Biochem; 1990 Nov 26; 194(1):43-9. PubMed ID: 2174781
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X, Williams JA, Deadman JJ, Salmon GP, Kakkar VV, Wilkinson JM, Baruch D, Authi KS, Rahman S.
    Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.